During the past decade, Central Maine Pulmonary Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Central Maine Pulmonary Associates" are "Anesthesia" (1 trials), "Bronchoscopy" (1 trials), "Cystic Fibrosis" (1 trials), "Intubation" (1 trials) and "Postoperative Sedation" (1 trials). Many other conditions were trialed in "Central Maine Pulmonary Associates" in a lesser frequency.

Most popular intervention types in "Central Maine Pulmonary Associates" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "AQUAVAN (fospropofol disodium; GPI 15715 )" (1 trials), "AQUAVAN® (fospropofol disodium) Injection" (1 trials), "AZLI 75 mg three times a day (TID)" (1 trials) and "Placebo three times a day (TID)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Maine Pulmonary Associates" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Central Maine Pulmonary Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Central Maine Pulmonary Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Maine Pulmonary Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".